338 related articles for article (PubMed ID: 37765185)
1. Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy.
Junyaprasert VB; Thummarati P
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765185
[TBL] [Abstract][Full Text] [Related]
2. Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview.
Javia A; Vanza J; Bardoliwala D; Ghosh S; Misra LA; Patel M; Thakkar H
Int J Pharm; 2022 Jul; 623():121863. PubMed ID: 35643347
[TBL] [Abstract][Full Text] [Related]
3. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
5. Drug Conjugates Using Different Dynamic Covalent Bonds and their Application in Cancer Therapy.
Theodosis-Nobelos P; Charalambous D; Triantis C; Rikkou-Kalourkoti M
Curr Drug Deliv; 2020; 17(7):542-557. PubMed ID: 32384029
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment.
Raval H; Bhattacharya S
Curr Med Chem; 2024 Apr; ():. PubMed ID: 38571347
[TBL] [Abstract][Full Text] [Related]
7. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
[TBL] [Abstract][Full Text] [Related]
8. A Review on Exploring the Opportunities of Polymer Drug Conjugated Systems for Targeted Cancer Treatment.
Gupta C; Naik I; Menon M; Ambre P; Coutinho E
Curr Drug Deliv; 2022; 20(1):8-30. PubMed ID: 35400344
[TBL] [Abstract][Full Text] [Related]
9. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
11. Polymer-Drug Conjugates for Anticancer Drug Delivery.
Wadhwa S; Mumper RJ
Crit Rev Ther Drug Carrier Syst; 2015; 32(3):215-45. PubMed ID: 26080809
[TBL] [Abstract][Full Text] [Related]
12. Polyethylene Glycol-Based Polymer-Drug Conjugates: Novel Design and Synthesis Strategies for Enhanced Therapeutic Efficacy and Targeted Drug Delivery.
Verma VS; Pandey A; Jha AK; Badwaik HKR; Alexander A; Ajazuddin
Appl Biochem Biotechnol; 2024 Mar; ():. PubMed ID: 38519751
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies.
Ulbrich K; Holá K; Šubr V; Bakandritsos A; Tuček J; Zbořil R
Chem Rev; 2016 May; 116(9):5338-431. PubMed ID: 27109701
[TBL] [Abstract][Full Text] [Related]
15. PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents.
Senevirathne SA; Washington KE; Biewer MC; Stefan MC
J Mater Chem B; 2016 Jan; 4(3):360-370. PubMed ID: 32263202
[TBL] [Abstract][Full Text] [Related]
16. Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy.
Tao W; Zhang J; Zeng X; Liu D; Liu G; Zhu X; Liu Y; Yu Q; Huang L; Mei L
Adv Healthc Mater; 2015 Jun; 4(8):1203-14. PubMed ID: 25800699
[TBL] [Abstract][Full Text] [Related]
17. Recent advances of polymer based nanosystems in cancer management.
Janrao C; Khopade S; Bavaskar A; Gomte SS; Agnihotri TG; Jain A
J Biomater Sci Polym Ed; 2023 Jun; 34(9):1274-1335. PubMed ID: 36542375
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
19. Polymeric micelles in cancer therapy: State of the art.
Ghosh B; Biswas S
J Control Release; 2021 Apr; 332():127-147. PubMed ID: 33609621
[TBL] [Abstract][Full Text] [Related]
20. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
